A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretrovira...

von de Boer, Alberdina W
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2003)